143 related articles for article (PubMed ID: 18577664)
1. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings.
Fleischer AC; Lyshchik A; Jones HW; Crispens M; Loveless M; Andreotti RF; Williams PK; Fishman DA
J Ultrasound Med; 2008 Jul; 27(7):1011-8; quiz 1019-21. PubMed ID: 18577664
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.
Fleischer AC; Lyshchik A; Jones HW; Crispens MA; Andreotti RF; Williams PK; Fishman DA
J Ultrasound Med; 2009 Oct; 28(10):1273-80. PubMed ID: 19778872
[TBL] [Abstract][Full Text] [Related]
3. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.
Testa AC; Timmerman D; Exacoustos C; Fruscella E; Van Holsbeke C; Bokor D; Arduini D; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2007 May; 29(5):512-6. PubMed ID: 17444549
[TBL] [Abstract][Full Text] [Related]
4. Combination of 2- and 3-dimensional contrast-enhanced transvaginal sonography for diagnosis of small adnexal masses.
Hu R; Xiang H; Mu Y; Feng Y; Gu L; Liu H
J Ultrasound Med; 2014 Nov; 33(11):1889-99. PubMed ID: 25336475
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.
Marret H; Sauget S; Giraudeau B; Brewer M; Ranger-Moore J; Body G; Tranquart F
J Ultrasound Med; 2004 Dec; 23(12):1629-39; quiz 1641-42. PubMed ID: 15557306
[TBL] [Abstract][Full Text] [Related]
6. Parametric mapping of contrasted ovarian transvaginal sonography.
Korhonen K; Moore R; Lyshchik A; Fleischer AC
Ultrasound Q; 2015 Jun; 31(2):117-23. PubMed ID: 26002525
[TBL] [Abstract][Full Text] [Related]
7. [Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses].
Zhou Q; Liu BL; Jiang J; Lei XY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2007-9. PubMed ID: 19861251
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal color Doppler imaging in the detection of ovarian cancer in a large study population.
Guerriero S; Alcazar JL; Ajossa S; Galvan R; Laparte C; García-Manero M; Lopez-Garcia G; Melis GB
Int J Gynecol Cancer; 2010 Jul; 20(5):781-6. PubMed ID: 20973268
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses.
Kupesic S; Kurjak A
Obstet Gynecol; 2000 Sep; 96(3):452-8. PubMed ID: 10960641
[TBL] [Abstract][Full Text] [Related]
10. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
Testa AC; Timmerman D; Van Belle V; Fruscella E; Van Holsbeke C; Savelli L; Ferrazzi E; Leone FP; Marret H; Tranquart F; Exacoustos C; Nazzaro G; Bokor D; Magri F; Van Huffel S; Ferrandina G; Valentin L
Ultrasound Obstet Gynecol; 2009 Dec; 34(6):699-710. PubMed ID: 19924735
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.
Nakata N; Ohta T; Nishioka M; Takeyama H; Toriumi Y; Kato K; Nogi H; Kamio M; Fukuda K
J Ultrasound Med; 2015 Nov; 34(11):1969-76. PubMed ID: 26384607
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses.
Ordén MR; Gudmundsson S; Kirkinen P
J Ultrasound Med; 2000 Nov; 19(11):783-8. PubMed ID: 11065267
[TBL] [Abstract][Full Text] [Related]
13. Can contrast-enhanced sonography distinguish benign from malignant breast masses?
Sorelli PG; Cosgrove DO; Svensson WE; Zaman N; Satchithananda K; Barrett NK; Lim AK
J Clin Ultrasound; 2010 May; 38(4):177-81. PubMed ID: 20146214
[TBL] [Abstract][Full Text] [Related]
14. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
Kook SH; Kwag HJ
J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
[TBL] [Abstract][Full Text] [Related]
15. Transvaginal color Doppler and CA125 as tools in the differential diagnosis of postmenopausal ovarian masses.
Botsis D; Kassanos D; Kalogirou D; Karakitsos P; Liapis A; Antoniou G
Maturitas; 1997 Apr; 26(3):203-9. PubMed ID: 9147352
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses.
Reles A; Wein U; Lichtenegger W
J Clin Ultrasound; 1997 Jun; 25(5):217-25. PubMed ID: 9314102
[TBL] [Abstract][Full Text] [Related]
17. Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?
Mansour SM; Saraya S; El-Faissal Y
Br J Radiol; 2015 Sep; 88(1053):20150099. PubMed ID: 26083260
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
[TBL] [Abstract][Full Text] [Related]
19. Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic tumors to the ovary.
Alcázar JL; Galán MJ; Ceamanos C; García-Manero M
J Ultrasound Med; 2003 Mar; 22(3):243-7. PubMed ID: 12636323
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
